Safety and efficacy of sodium glucose co-transporter 2 inhibitors combined with insulin in adults with type 1 diabetes: A meta-analysis of randomized controlled trials [0.03%]
钠葡萄糖协同转运蛋白2抑制剂与胰岛素联合使用治疗1型糖尿病成人患者的疗效和安全性：随机对照试验的meta分析
Kexin Li,Gaosi Xu
Kexin Li
Background: The safety and efficacy of sodium glucose co-transporter 2 (SGLT2) inhibitors in a dose-dependent manner for type 1 diabetes mellitus (T1DM) are unclear. ...
Meta-Analysis
Journal of diabetes. 2019 Aug;11(8):645-655. DOI:10.1111/1753-0407.12890 2019
Notes from the world congress on insulin resistance, diabetes, and cardiovascular disease [0.03%]
全球胰岛素抵抗、糖尿病和心血管疾病大会记要
Zachary Bloomgarden,Yehuda Handelsman
Zachary Bloomgarden
Trends in medication utilization, glycemic control and outcomes among type 2 diabetes patients in a tertiary referral center in Singapore from 2007 to 2017 [0.03%]
新加坡三甲医院2型糖尿病患者的用药趋势、血糖控制及预后（2007—2017年）
Yan Zhi Tan,McVin Hua Heng Cheen,Su-Yen Goh et al.
Yan Zhi Tan et al.
Background: Use of glucose-lowering agents is a cornerstone in combating type 2 diabetes (T2DM). Treatment guidelines have changed significantly over the past decade. We report temporal trends in medication utilization, g...
Higher blood pressure predicts diabetes and enhances long-term risk of cardiovascular disease events in individuals with impaired glucose tolerance: Twenty-three-year follow-up of the Daqing diabetes prevention study [0.03%]
较高血压预测糖尿病并增加糖耐量受损个体长期心血管疾病风险：大庆糖尿病预防研究23年随访
Xiaojue Li,Jinping Wang,Xiaoxia Shen et al.
Xiaojue Li et al.
Background: Hypertension is more prevalent in subjects with impaired glucose tolerance (IGT), but whether higher blood pressure per se or the mild hyperglycemia in combination with the hypertension enhanced the risk of ca...
Randomized Controlled Trial
Journal of diabetes. 2019 Jul;11(7):593-598. DOI:10.1111/1753-0407.12887 2019
Protracted glycosuria after discontinuation of sodium-glucose cotransporter 2 inhibitors: Implications for weekly dosing and extended risk of euglycemic diabetes ketoacidosis [0.03%]
钠-葡萄糖共转运蛋白2抑制剂停药后的持续性酮症酸中毒：对每周给药及非低血糖糖尿病酮症酸中毒风险的启示
Sharifa Alhassan,Michael Rudoni,Maria A Alfonso-Jaume et al.
Sharifa Alhassan et al.
Case Reports
Journal of diabetes. 2019 May;11(5):410-411. DOI:10.1111/1753-0407.12885 2019
Martin J Kurian,Peter J Rentzepis,Ann M Carracher et al.
Martin J Kurian et al.
Martin J. Kurian, Peter J. Rentzepis, Ann M. Carracher, and Kelly L. Close are of Close Concerns (http://www.closeconcerns.com), a healthcare information company focused exclusively on diabetes and obesity care. Close Concerns publishes Clo...
Role of metabolic syndrome and its components as mediators of the genetic effect on type 2 diabetes: A family-based study in China [0.03%]
代谢综合征及其组分在中国人群中的糖尿病遗传效应中介作用：基于家系的队列研究
Jing Song,Xia Jiang,Juan Juan et al.
Jing Song et al.
Background: Metabolic syndrome (MetS) share a genetic basis with type 2 diabetes (T2D). However, whether MetS and its components mediate genetic susceptibility to T2D is not completely understood. ...
Combined effect of GABA and glucagon-like peptide-1 receptor agonist on cytokine-induced apoptosis in pancreatic β-cell line and isolated human islets [0.03%]
GABA与胰高血糖素样肽-1受体激动剂对细胞因子诱导的胰岛β细胞系和人分离胰岛细胞凋亡的联合作用研究
Dong Ok Son,Wenjuan Liu,Xiaoming Li et al.
Dong Ok Son et al.
Background: Treatment with GABA or glucagon-like peptide-1 (GLP-1) can preserve pancreatic β-cell mass and prevent diabetes. Recently, we reported that the combination of GABA and sitagliptin (a dipeptidyl peptidase-4 in...
Effect of baseline body mass index on glycemic control and weight change with exenatide monotherapy in Chinese drug-naïve type 2 diabetic patients [0.03%]
基线体重指数对中国初诊2型糖尿病患者单用艾塞那肽治疗的血糖控制和体重变化的影响
Hongrong Deng,Shuo Lin,Xubin Yang et al.
Hongrong Deng et al.
Background: The weight-reducing effect of exenatide has been proved, but too much weight loss in normal-weight patients may concern physicians. This study evaluated the effects of exenatide monotherapy on glycemic control...
Randomized Controlled Trial
Journal of diabetes. 2019 Jul;11(7):509-518. DOI:10.1111/1753-0407.12883 2019
Zachary Bloomgarden,Robert Chilton
Zachary Bloomgarden